Vidcast:

https://youtu.be/VTzUP8sHGJs

 

An NSAID that selectively and safely blocks inflammation may be another weapon in the fight against the novel coronavirus.   A preliminary Chinese study of 44 CoVid patients included 37 receiving Celebrex and a very small 7 patient control group receiving conventional therapy only.

 

Data showed that treatment with Celebrex was associated with recovery of all 29 CoVid patients with moderate disease and 82% of those with severe disease.  In contrast, only 57% of the control group recovered.

 

Celebrex is a powerful drugs with significant side effects including skin reactions, liver issues, potential kidney toxicity, gi upset, and elevated blood pressure.  We’ll see if more studies confirm its usefulness for CoVid.

 

https://www.medrxiv.org/content/10.1101/2020.05.05.20077610v1.full.pdf

 

#covid #pandemic #celebrex #cox2inhibitors #nsaids